Detalhe da pesquisa
1.
Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study.
Neurol Ther
; 12(6): 2177-2193, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37861931
2.
Parkinson's Disease Motor Subtypes Change with the Progression of the Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up.
J Parkinsons Dis
; 12(3): 935-955, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34957949
3.
Diplopia Is Frequent and Associated with Motor and Non-Motor Severity in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up.
Diagnostics (Basel)
; 11(12)2021 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34943619
4.
Predictors of Global Non-Motor Symptoms Burden Progression in Parkinson's Disease. Results from the COPPADIS Cohort at 2-Year Follow-Up.
J Pers Med
; 11(7)2021 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34209166
5.
Predictors of Loss of Functional Independence in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up and Comparison with a Control Group.
Diagnostics (Basel)
; 11(10)2021 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34679503